id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0389-0004,FDA,FDA-2011-E-0389,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2011-06-23T04:00:00Z,2011,6,2011-06-23T04:00:00Z,,2011-06-23T15:04:17Z,,0,0,0900006480e9c221
FDA-2011-E-0389-0002,FDA,FDA-2011-E-0389,Merk Patent GnbH - Letter,Other,LET-Letter,2011-05-20T04:00:00Z,2011,5,2011-05-20T04:00:00Z,,2011-05-20T14:19:31Z,,0,0,0900006480dbbeb6
FDA-2011-E-0389-0003,FDA,FDA-2011-E-0389,U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-05-20T04:00:00Z,2011,5,2011-05-20T04:00:00Z,,2013-07-27T23:53:41Z,,0,0,0900006480dbbeb7
FDA-2011-E-0389-0001,FDA,FDA-2011-E-0389,Merk Patent GmbH (McCarter & English LLP) - Patent Extension Application,Other,AAV-Approval of Application,2011-05-20T04:00:00Z,2011,5,2011-05-20T04:00:00Z,,2013-07-27T23:53:41Z,,0,0,0900006480dbbeb5